LCBiot-GSTSGSGKPGSGEGSTKG-NH2

Ref. 3D-PP49628

Produktinformation

• Name: LCBiot-GSTSGSGKPGSGEGSTKG-NH2

Beschreibung

Peptide LCBiot-GSTSGSGKPGSGEGSTKG-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-GSTSGSGKPGSGEGSTKG-NH2 include the following: Switchable CAR-T cells outperformed traditional antibody-redirected therapeutics targeting breast cancers YJ Cao, X Wang, Z Wang, L Zhao, S Li - ACS Synthetic , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acssynbio.1c00007 Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu Y Cao, KA Mohamedali , JW Marks, LH Cheung - Molecular cancer , 2013 - AACRhttps://aacrjournals.org/mct/article-abstract/12/6/979/91795 Periplasmic expression, purification, and characterization of an anti-epidermal growth factor receptor antibody fragment in Escherichia coli WJ Chi, H Kim, H Yoo, YP Kim, SK Hong - Biotechnology and Bioprocess , 2016 - Springerhttps://link.springer.com/article/10.1007/s12257-015-0817-2 Novel avian single-chain fragment variable (scFv) targets dietary gluten and related natural grain prolamins, toxic entities of celiac disease V Stadlmann, H Harant , I Korschineck, M Hermann - BMC , 2015 - Springerhttps://link.springer.com/article/10.1186/s12896-015-0223-z Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon UH Weidle, G Georges - Cancer genomics & , 2012 - cgp.iiarjournals.orghttps://cgp.iiarjournals.org/content/9/3/119.short Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity TB Shabaneh, AR Stevens, SM Stull - for ImmunoTherapy of , 2024 - jitc.bmj.comhttps://jitc.bmj.com/content/12/2/e008566.abstract Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor T Schirrmann, G Pecher - Leukemia research, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0145212604002474 Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas T Olafsen , D Betting, VE Kenanova - Journal of Nuclear , 2009 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/50/9/1500.short Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression P Della Cristina, M Castagna, A Lombardi - Microbial cell , 2015 - Springerhttps://link.springer.com/article/10.1186/s12934-015-0202-z An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability M Whitlow, BA Bell, SL Feng, D Filpula - Protein Engineering , 1993 - academic.oup.comhttps://academic.oup.com/peds/article-abstract/6/8/989/1559790 Design and Synthesis of Collagen-binding Anti-microbial Proteins M Ghannad - 2011 - search.proquest.comhttps://search.proquest.com/openview/c8198ec1ee816065bc1bdc24b210e72d/1.pdf?pq-origsite=gscholar&cbl=18750 Generation of BiKEs and TriKEs to improve NK cell-mediated targeting of tumor cells M Felices, TR Lenvik, ZB Davis, JS Miller - Natural Killer Cells , 2016 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-3684-7_28 Construction of CD19 targeted dual-and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy M Chen, X Liu, N Peng, T Zhang, J Mou, H He - Hematology & Oncology, 2023 - Springerhttps://link.springer.com/article/10.1186/s40164-023-00423-0 T-cell clones can be rendered specific for CD19: Toward the selective augmentation of the graft-versus-B-lineage leukemia effect LJN Cooper, MS Topp, LM Serrano - Blood, The Journal , 2003 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/101/4/1637/105992 Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes L di Leandro, M Colasante, G Pitari, R Ippoliti - Toxins, 2023 - mdpi.comhttps://www.mdpi.com/2072-6651/15/12/699 Employing T Cells For Antigen Presentation: Role Of Ny-Eso-1+ T-Apc Vaccine In Multiple Myeloma KK Patel - 2016 - digitalcommons.library.tmc.eduhttps://digitalcommons.library.tmc.edu/utgsbs_dissertations/707/ Development of a deimmunized bispecific immunotoxin dDT2219 against B-cell malignancies JU Schmohl, D Todhunter, E Taras, V Bachanova - Toxins, 2018 - mdpi.comhttps://www.mdpi.com/2072-6651/10/1/32 Bispecific antibody binding to RANKL and osteonectin with enhanced localization to the bone JH Chen, CY Lin, YCM Chen, WT Tian - Molecular , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00501 Crystal Structure of a Chimeric Antigen Receptor (CAR) scFv Domain Rearrangement Forming a VL-VL Dimer J Cheung, S Wazir, DR Bell , JN Kochenderfer - Crystals, 2023 - mdpi.comhttps://www.mdpi.com/2073-4352/13/4/710 Magnetic CAR T cell purification using an anti-G4S linker antibody DC Harrer , SS Li, M Kaljanac, V Bezler - Journal of , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175924000528 Antitumor and antimetastatic activity of IL-23 CH Lo, SC Lee, PY Wu, WY Pan, J Su - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/2/600/35913 Early Development of C3aR1-Targeting Chimeric Antigen Receptor T Cells for the Treatment of Glioblastoma multiforme C Fraser - 2023 - scholarworks.lib.csusb.eduhttps://scholarworks.lib.csusb.edu/etd/1823/

• Marke: Biosynth